BlackRock Fund Advisors’s Decoy Therapeutics DCOY Stock Holding History

BlackRock Fund Advisors’s Portfolio DCOY Stock Details DCOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1	Closed	-$6.1M	–	3179
2016 Q3	$6.28M	Hold	1	–	–	﹤0.01%	2736
2016 Q2	$5.13M	Buy	+1	New	+$10.3M	﹤0.01%	2787
2016 Q1	–	Hold	0	–	–	–	2846
2015 Q4	–	Hold	0	–	–	–	2888
2015 Q3	–	Hold	0	–	–	–	3144
2015 Q2	–	Hold	0	–	–	–	3125
2015 Q1	–	Hold	0	–	–	–	3052

Other funds holding DCOY

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

BlackRock Fund Advisors's DCOY Position: Q4 2016 in Review

BlackRock Fund Advisors sold out of Decoy Therapeutics (DCOY) in Q4 2016, closing a stake of 1 share — an estimated $6.1M sold.

BlackRock Fund Advisors first reported a position in DCOY in Q2 2016 and held it in 2 quarters. The position peaked at $6.28M in Q3 2016. 3 funds tracked by Wall St. Rank hold DCOY as of Q4 2016.

BlackRock Fund Advisors reported no remaining Decoy Therapeutics position as of Q4 2016 after selling out during the quarter.
BlackRock Fund Advisors sold 1 Decoy Therapeutics share in Q4 2016, an estimated $6.1M.
BlackRock Fund Advisors first reported a position in Decoy Therapeutics in Q2 2016 and held it in 2 quarters.
BlackRock Fund Advisors's Decoy Therapeutics position peaked at $6.28M in Q3 2016.
3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.